USMLE Abandons Plan for Shorter Tests After Backlash


The United States Medical Licensing Examination (USMLE) will not offer a reduced-length test to some students taking Step 1 and Step 2 Clinical Knowledge (CK) exams.

A spokesperson for the National Board of Medical Examiners (NBME) told Medscape Medical News, “Last week, in order to make testing more rapidly and widely available, the USMLE program announced plans to provide its exams at reduced length at certain test sites by excluding unscored questions. 

“After hearing the concerns of examinees about perceived inequities, we have decided to administer standard length forms that include unscored questions at all testing sites. While we have evidence to support the score comparability and test fairness of the original plan, we do not want to take an action that may cause additional stress or confusion. We appreciate the feedback and remain committed to supporting fair and standard testing conditions to every extent possible while we address the situation this pandemic has created.

“We recognize that reduced length testing for all examinees may be desirable, but we are unable to sustain the quality of the USMLE program on behalf of state medical boards without unscored questions. The use of unscored questions is a standardized practice for professional licensure and other assessments to maintain the quality and fairness of those assessments.”

The original plan was met with immediate backlash on social media.

Last Thursday, the NBME announced that a shorter version of the examinations would be made available to those participating in event-based testing held at medical schools in July and August.

At those sites, the Step 1 event test would have 200 items (instead of up to 280), whereas the Step 2 CK event test would have 240 items (instead of up to 318). Those changes would have cut approximately 2 hours from the total 8-hour test time. This was to include the elimination of experimental questions, or questions that are not scored but are used to determine whether they are valid indicators of a test-taker’s performance.

Some critics argued that students taking shorter exams would have an advantage on a test that can greatly influence their path as physicians.

COVID-19 Continues to Wreak Havoc

COVID-19 resulted in the closing of many sites by Prometric, the organization that facilitates USMLE testing, forcing students to upend plans or delay steps.

Although a gradual reopening has begun at Prometric, a backlog remains. The USMLE has responded with a “phased-in plan.” The intent is to enable students to have the necessary testing completed prior to applying for residency in the fall. Phase 1 includes regional testing at approximately six medical schools, using Prometric equipment. Phase 2 involves administering 1-day, large event-based tests for Step 1 and Step 2 CK at medical schools. Those were the tests slated to be shorter, prior to the USMLE’s reversal of its decision.

The announcement of shorter tests and different test content set off an uproar on social media.

Evan Keil, whose profile says he is a “newly minted M3” student, was among those launching criticism of the announcement on Twitter.

He tweeted: “EQUITY?! Equity for test-takers would look like nothing else but moving to Pass/Fail. The ghosting, the cancellations, the indecisiveness, the formation of two different length tests - it all needs to stop.”

Bryan Carmody, MD, MPH, an assistant professor at Eastern Virginia Medical School in Norfolk, Virginia, told Medscape Medical News, “The test is a grueling test. Part of the testing experience is endurance, in doing these questions in a high-pressure, high-stakes environment with no time to spare all day long. Cutting that off by even a couple of hours seems like it would give the students who test that way an unfair advantage.”

The change and subsequent rapid reversal is the latest in a series of decisions by the USMLE that has left students confused and upset. Those affected are still waiting for further clarity and guidance on testing availability. Today’s statement from the NBME indicates that they are aware of the concern. “We remain committed to expanding USMLE testing capacity and keeping you informed of our plans.”

Marcia Frellick is a freelance journalist based in Chicago. She has previously written for the Chicago Tribune and and was an editor at the Chicago Sun-Times, the Cincinnati Enquirer, and the St. Cloud (Minnesota) Times. Follow her on Twitter at @mfrellick.

Carmody has disclosed no relevant financial relationships.

For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube.

Leave a Reply

Your email address will not be published. Required fields are marked *